Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Insider Analysis from Perkins Coie: China IP Intelligence Briefing

This article was originally published in PharmAsia News

Executive Summary

China IP Intelligence Briefing is a periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry. The last installment of this series appeared October 2008 (PharmaAsia News, Oct. 27, 2008).

You may also be interested in...



Insider Analysis from Perkins Coie: China IP Intelligence Briefing

China IP Intelligence Briefing is a periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry. The last installment of this series appeared in March 2009 (PharmaAsia News, March 16, 2009).

Insider Analysis from Perkins Coie: China IP Intelligence Briefing

China IP Intelligence Briefing is a periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry. The last installment of this series appeared in March 2009 (PharmaAsia News, March 16, 2009).

Insider Analysis From Perkins Coie LLP: China IP Intelligence Briefing

ChinaIP Intelligence Briefing is a periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry. The first installment of this series appeared in July (PharmAsia News, July 17, 2008).

Table

View full table

Tags:
Latest Headlines

Metsera Launches As New Obesity Contender Flush With $290m

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel

Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

See All
UsernamePublicRestriction

Register

SC071050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By